SummitTX Capital »

Castle Biosciences shares owned by SummitTX Capital

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 45k 22.77

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Cisco Systems (CSCO)
MKS Instruments (MKSI)
NVIDIA Corporation (NVDA)
Cyberark Software SHS (CYBR)
PPL Corporation (PPL)
Meritage Homes Corporation (MTH)
Toll Brothers (TOL)
Teradyne (TER)
Applied Materials (AMAT)
Griffon Corporation (GFF)
Owens Corning (OC)

View all positions for SummitTX Capital

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Nuveen
Braidwell
State Street Corporation
AIGH Capital Management
Geode Capital Management
Daniel D. Thurber
Allianz Asset Management
Palisade Capital Management
Millennium Management
Renaissance Technologies

View all funds holding Castle Biosciences